{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:54Z","timestamp":1786981494444,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Project of Zhejiang Provincial Department of Education","award":["Y202250025"],"award-info":[{"award-number":["Y202250025"]}]},{"name":"Program of Wenzhou Association for Integrated Chinese and Western Medicine","award":["2021002"],"award-info":[{"award-number":["2021002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05524-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:52:57Z","timestamp":1775123577000},"page":"2119-2137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["S-equol promotes ferroptosis in triple negative breast cancer by coordinating NCOA4-mediated ferritinophagy and PPAR\u03b3-mediated lipid metabolism"],"prefix":"10.1007","volume":"481","author":[{"given":"Fubiao","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuekai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"5524_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321:288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323","journal-title":"JAMA"},{"key":"5524_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113552","volume":"28","author":"S Zheng","year":"2025","unstructured":"Zheng S, Chan C, Asara JM, Zhang L, Wiche G, Chin YR (2025) Phosphorylation of plectin by Akt3 promotes triple-negative breast cancer cell invasive migration. iScience 28:113552. https:\/\/doi.org\/10.1016\/j.isci.2025.113552","journal-title":"iScience"},{"key":"5524_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040916","author":"E Vagia","year":"2020","unstructured":"Vagia E, Mahalingam D, Cristofanilli M (2020) The landscape of targeted therapies in TNBC. Cancers. https:\/\/doi.org\/10.3390\/cancers12040916","journal-title":"Cancers"},{"key":"5524_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110652","author":"M Wichtowski","year":"2025","unstructured":"Wichtowski M, Ko\u0142aci\u0144ska-Wow A, Skrzypek K, Jab\u0142o\u0144ska E, P\u0142oszka K, Ko\u0142at D, Paszek S, Zawlik I, P\u0142uciennik E, Potocka N (2025) Molecular implications of ADIPOQ, GAS5, GATA4, and YAP1 methylation in triple-negative breast cancer prognosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262110652","journal-title":"Int J Mol Sci"},{"key":"5524_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13046-022-02373-7","volume":"41","author":"Z Li","year":"2022","unstructured":"Li Z, Yang HY, Zhang XL, Zhang X, Huang YZ, Dai XY, Shi L, Zhou GR, Wei JF, Ding Q (2022) Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt\/\u03b2-catenin pathway. J Exp Clin Cancer Res 41:168. https:\/\/doi.org\/10.1186\/s13046-022-02373-7","journal-title":"J Exp Clin Cancer Res"},{"key":"5524_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363:1938\u20131948. https:\/\/doi.org\/10.1056\/NEJMra1001389","journal-title":"N Engl J Med"},{"key":"5524_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"5524_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jare.2024.09.027","volume":"74","author":"G Huang","year":"2025","unstructured":"Huang G, Cai Y, Ren M, Zhang X, Fu Y, Cheng R, Wang Y, Miao M, Zhu L, Yan T (2025) Salidroside sensitizes triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. J Adv Res 74:589\u2013607. https:\/\/doi.org\/10.1016\/j.jare.2024.09.027","journal-title":"J Adv Res"},{"key":"5524_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, Shi JX, Huang W, Wang YP, Jiang YZ et al (2023) Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab 35:84-100.e108. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.021","journal-title":"Cell Metab"},{"key":"5524_CR10","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1007\/s11010-025-05305-z","volume":"480","author":"L Hu","year":"2025","unstructured":"Hu L, Hu J, Qin C, Liu S, Yu Y (2025) Ferroptosis in TNBC: interplay with tumor-infiltrating immune cells and therapeutic implications. Mol Cell Biochem 480:5029\u20135039. https:\/\/doi.org\/10.1007\/s11010-025-05305-z","journal-title":"Mol Cell Biochem"},{"key":"5524_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-025-00789-5","volume":"30","author":"Y Liu","year":"2025","unstructured":"Liu Y, He J, Chen J, Chen T, Li W, Yang Z, Zeng F (2025) Programmed cell death in triple-negative breast cancer. Cell Mol Biol Lett 30:111. https:\/\/doi.org\/10.1186\/s11658-025-00789-5","journal-title":"Cell Mol Biol Lett"},{"key":"5524_CR12","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.7314\/apjcp.2013.14.4.2191","volume":"14","author":"M Minatoya","year":"2013","unstructured":"Minatoya M, Kutomi G, Asakura S, Otokozawa S, Sugiyama Y, Nagata Y, Mori M, Hirata K (2013) Equol, adiponectin, insulin levels and risk of breast cancer. Asian Pac J Cancer Prevent 14:2191\u20132199. https:\/\/doi.org\/10.7314\/apjcp.2013.14.4.2191","journal-title":"Asian Pac J Cancer Prevent"},{"key":"5524_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1573403x15666181205104717","volume":"15","author":"A Sekikawa","year":"2019","unstructured":"Sekikawa A, Ihara M, Lopez O, Kakuta C, Lopresti B, Higashiyama A, Aizenstein H, Chang YF, Mathis C, Miyamoto Y et al (2019) Effect of S-equol and soy isoflavones on heart and brain. Curr Cardiol Rev 15:114\u2013135. https:\/\/doi.org\/10.2174\/1573403x15666181205104717","journal-title":"Curr Cardiol Rev"},{"key":"5524_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.intimp.2006.12.004","volume":"7","author":"JS Kang","year":"2007","unstructured":"Kang JS, Yoon YD, Han MH, Han SB, Lee K, Park SK, Kim HM (2007) Equol inhibits nitric oxide production and inducible nitric oxide synthase gene expression through down-regulating the activation of Akt. Int Immunopharmacol 7:491\u2013499. https:\/\/doi.org\/10.1016\/j.intimp.2006.12.004","journal-title":"Int Immunopharmacol"},{"key":"5524_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1749-6632.2009.04360.x","volume":"1155","author":"SJ Ellem","year":"2009","unstructured":"Ellem SJ, Risbridger GP (2009) The dual, opposing roles of estrogen in the prostate. Ann N Y Acad Sci 1155:174\u2013186. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04360.x","journal-title":"Ann N Y Acad Sci"},{"key":"5524_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108064","volume":"672","author":"J Zhang","year":"2019","unstructured":"Zhang J, Ren L, Yu M, Liu X, Ma W, Huang L, Li X, Ye X (2019) S-equol inhibits proliferation and promotes apoptosis of human breast cancer MCF-7\u202fcells via regulating miR-10a-5p and PI3K\/AKT pathway. Arch Biochem Biophys 672:108064. https:\/\/doi.org\/10.1016\/j.abb.2019.108064","journal-title":"Arch Biochem Biophys"},{"key":"5524_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041105","author":"R Hod","year":"2021","unstructured":"Hod R, Maniam S, Mohd Nor NH (2021) A systematic review of the effects of equol (soy metabolite) on breast cancer. Molecules. https:\/\/doi.org\/10.3390\/molecules26041105","journal-title":"Molecules"},{"key":"5524_CR18","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1080\/01635581.2017.1367945","volume":"69","author":"M Ono","year":"2017","unstructured":"Ono M, Ejima K, Higuchi T, Takeshima M, Wakimoto R, Nakano S (2017) Equol enhances apoptosis-inducing activity of genistein by increasing Bax\/Bcl-xL expression ratio in MCF-7 human breast cancer cells. Nutr Cancer 69:1300\u20131307. https:\/\/doi.org\/10.1080\/01635581.2017.1367945","journal-title":"Nutr Cancer"},{"key":"5524_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa021","author":"N Zhou","year":"2020","unstructured":"Zhou N, Bao J (2020) FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database J Biol Databases Curation. https:\/\/doi.org\/10.1093\/database\/baaa021","journal-title":"Database J Biol Databases Curation"},{"key":"5524_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00394-013-0520-z","volume":"53","author":"PJ Magee","year":"2014","unstructured":"Magee PJ, Allsopp P, Samaletdin A, Rowland IR (2014) Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2. Eur J Nutr 53:345\u2013350. https:\/\/doi.org\/10.1007\/s00394-013-0520-z","journal-title":"Eur J Nutr"},{"key":"5524_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02464-x","volume":"24","author":"T Ma","year":"2025","unstructured":"Ma T, Guo X, Zhao J, Wang C, Yu X, Mo R, Han Z, Feng L, Liu L, Yu W et al (2025) HPGD induces ferroptosis and autophagy to suppress esophageal squamous cell carcinoma through the LXA4-ERK1\/2-U2AF2-TFRC axis. Mol Cancer 24:241. https:\/\/doi.org\/10.1186\/s12943-025-02464-x","journal-title":"Mol Cancer"},{"key":"5524_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13062-024-00519-5","volume":"19","author":"XM Liu","year":"2024","unstructured":"Liu XM, Wang ZH, Wei QX, Song Y, Ma XX (2024) Equol exerts anti-tumor effects on choriocarcinoma cells by promoting TRIM21-mediated ubiquitination of ANXA2. Biol Direct 19:78. https:\/\/doi.org\/10.1186\/s13062-024-00519-5","journal-title":"Biol Direct"},{"key":"5524_CR23","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1021\/acs.jmedchem.5b01641","volume":"59","author":"S Hofmans","year":"2016","unstructured":"Hofmans S, Vanden Berghe T, Devisscher L, Hassannia B, Lyssens S, Joossens J, Van Der Veken P, Vandenabeele P, Augustyns K (2016) Novel ferroptosis inhibitors with improved potency and ADME properties. J Med Chem 59:2041\u20132053. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01641","journal-title":"J Med Chem"},{"key":"5524_CR24","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.1021\/acs.jmedchem.8b01299","volume":"61","author":"L Devisscher","year":"2018","unstructured":"Devisscher L, Van Coillie S, Hofmans S, Van Rompaey D, Goossens K, Meul E, Maes L, De Winter H, Van Der Veken P, Vandenabeele P et al (2018) Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy. J Med Chem 61:10126\u201310140. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01299","journal-title":"J Med Chem"},{"key":"5524_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509:105\u2013109. https:\/\/doi.org\/10.1038\/nature13148","journal-title":"Nature"},{"key":"5524_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z (2024) GPX4, ferroptosis, and diseases. Biomed Pharmacother =\u2009Biomed Pharmacother 174:116512. https:\/\/doi.org\/10.1016\/j.biopha.2024.116512","journal-title":"Biomed Pharmacother =\u2009Biomed Pharmacother"},{"key":"5524_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s42003-024-06063-2","volume":"7","author":"W Lai","year":"2024","unstructured":"Lai W, Yu L, Deng Y (2024) PPAR\u03b3 alleviates preeclampsia development by regulating lipid metabolism and ferroptosis. Commun Biol 7:429. https:\/\/doi.org\/10.1038\/s42003-024-06063-2","journal-title":"Commun Biol"},{"key":"5524_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1645438","volume":"15","author":"PA Mir","year":"2025","unstructured":"Mir PA, Kumar N, Gupta SK, Kaur A, Farooq S, Sandhu GS, Kumar A (2025) Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategies. Front Oncol 15:1645438. https:\/\/doi.org\/10.3389\/fonc.2025.1645438","journal-title":"Front Oncol"},{"key":"5524_CR29","doi-asserted-by":"publisher","first-page":"1369s","DOI":"10.3945\/jn.109.118323","volume":"140","author":"JW Lampe","year":"2010","unstructured":"Lampe JW (2010) Emerging research on equol and cancer. J Nutr 140:1369s\u20131372s. https:\/\/doi.org\/10.3945\/jn.109.118323","journal-title":"J Nutr"},{"key":"5524_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/jjco\/hyh015","volume":"34","author":"H Akaza","year":"2004","unstructured":"Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM et al (2004) Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34:86\u201389. https:\/\/doi.org\/10.1093\/jjco\/hyh015","journal-title":"Jpn J Clin Oncol"},{"key":"5524_CR31","doi-asserted-by":"publisher","first-page":"50002","DOI":"10.18632\/oncotarget.18442","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Viswanadhapalli S, Garcia L, Zhou M, Nair BC, Kost E, Rao Tekmal R, Li R, Rao MK, Curiel T et al (2017) Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer. Oncotarget 8:50002\u201350014. https:\/\/doi.org\/10.18632\/oncotarget.18442","journal-title":"Oncotarget"},{"key":"5524_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/carcin\/bgy158","volume":"40","author":"E Norden","year":"2019","unstructured":"Norden E, Heiss EH (2019) Urolithin A gains in antiproliferative capacity by reducing the glycolytic potential via the p53\/TIGAR axis in colon cancer cells. Carcinogenesis 40:93\u2013101. https:\/\/doi.org\/10.1093\/carcin\/bgy158","journal-title":"Carcinogenesis"},{"key":"5524_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2973-y","volume":"16","author":"S Sch\u00fcler-Toprak","year":"2016","unstructured":"Sch\u00fcler-Toprak S, H\u00e4ring J, Inwald EC, Moehle C, Ortmann O, Treeck O (2016) Agonists and knockdown of estrogen receptor \u03b2 differentially affect invasion of triple-negative breast cancer cells in vitro. BMC Cancer 16:951. https:\/\/doi.org\/10.1186\/s12885-016-2973-y","journal-title":"BMC Cancer"},{"key":"5524_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba8968","author":"N Verma","year":"2020","unstructured":"Verma N, Vinik Y, Saroha A, Nair NU, Ruppin E, Mills G, Karn T, Dubey V, Khera L, Raj H (2020) Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aba8968","journal-title":"Sci Adv"},{"key":"5524_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1284057","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, He D, Li S, Xiao J, Zhu Z (2023) Ferroptosis: the emerging player in remodeling triple-negative breast cancer. Front Immunol 14:1284057. https:\/\/doi.org\/10.3389\/fimmu.2023.1284057","journal-title":"Front Immunol"},{"key":"5524_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.breast.2017.11.009","volume":"38","author":"M Laranjo","year":"2018","unstructured":"Laranjo M, Carvalho MJ, Costa T, Alves A, Oliveira RC, Casalta-Lopes J, Cordeiro P, Botas F, Abrantes AM, Paiva A et al (2018) Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype. Breast 38:22\u201329. https:\/\/doi.org\/10.1016\/j.breast.2017.11.009","journal-title":"Breast"},{"key":"5524_CR37","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3892\/ijo.2014.2778","volume":"46","author":"O Hinsche","year":"2015","unstructured":"Hinsche O, Girgert R, Emons G, Gr\u00fcndker C (2015) Estrogen receptor \u03b2 selective agonists reduce invasiveness of triple-negative breast cancer cells. Int J Oncol 46:878\u2013884. https:\/\/doi.org\/10.3892\/ijo.2014.2778","journal-title":"Int J Oncol"},{"key":"5524_CR38","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR, Jiang X (2023) Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186:2748-2764e.e2722. https:\/\/doi.org\/10.1016\/j.cell.2023.05.003","journal-title":"Cell"},{"key":"5524_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102308","author":"JH Park","year":"2020","unstructured":"Park JH, Pyun WY, Park HW (2020) Cancer metabolism: phenotype, signaling and therapeutic targets. Cells. https:\/\/doi.org\/10.3390\/cells9102308","journal-title":"Cells"},{"key":"5524_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD (2020) The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer 20:74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7","journal-title":"Nat Rev Cancer"},{"key":"5524_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-05940-w","volume":"617","author":"JS Bergholz","year":"2023","unstructured":"Bergholz JS, Wang Q, Wang Q, Ramseier M, Prakadan S, Wang W, Fang R, Kabraji S, Zhou Q, Gray GK et al (2023) Pi3k\u03b2 controls immune evasion in PTEN-deficient breast tumours. Nature 617:139\u2013146. https:\/\/doi.org\/10.1038\/s41586-023-05940-w","journal-title":"Nature"},{"key":"5524_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073157","author":"W Fu","year":"2023","unstructured":"Fu W, Wu G (2023) Targeting mTOR for anti-aging and anti-cancer therapy. Molecules. https:\/\/doi.org\/10.3390\/molecules28073157","journal-title":"Molecules"},{"key":"5524_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01258-7","volume":"19","author":"S Zou","year":"2020","unstructured":"Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X (2020) Targeting STAT3 in cancer immunotherapy. Mol Cancer 19:145. https:\/\/doi.org\/10.1186\/s12943-020-01258-7","journal-title":"Mol Cancer"},{"key":"5524_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06643-4","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou X, Zhao J, Yan T, Ye D, Wang Y, Zhou B, Liu D, Wang X, Zheng W, Zheng B et al (2024) ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway. Cell Death Dis 15:260. https:\/\/doi.org\/10.1038\/s41419-024-06643-4","journal-title":"Cell Death Dis"},{"key":"5524_CR45","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.neo.2021.08.003","volume":"23","author":"AP Morelli","year":"2021","unstructured":"Morelli AP, Tortelli TC Jr., Mancini MCS, Pavan ICB, Silva LGS, Severino MB, Granato DC, Pestana NF, Ponte LGS, Peruca GF et al (2021) STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma. Neoplasia 23:1048\u20131058. https:\/\/doi.org\/10.1016\/j.neo.2021.08.003","journal-title":"Neoplasia"},{"key":"5524_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103775","volume":"86","author":"A Maimon","year":"2025","unstructured":"Maimon A, Puzzovio PG, Vinik Y, Hannuna GD, Donzelli S, Rutigliano D, Blandino G, Lev S (2025) PNKP targeting engages the autophagic machinery through STING and STAT3 to potentiate ferroptosis and chemotherapy in TNBC. Redox Biol 86:103775. https:\/\/doi.org\/10.1016\/j.redox.2025.103775","journal-title":"Redox Biol"},{"key":"5524_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051529","author":"L Mar\u00e9chal","year":"2018","unstructured":"Mar\u00e9chal L, Laviolette M, Rodrigue-Way A, Sow B, Brochu M, Caron V, Tremblay A (2018) The CD36-PPAR\u03b3 pathway in metabolic disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19051529","journal-title":"Int J Mol Sci"},{"key":"5524_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202417326","volume":"12","author":"L Chen","year":"2025","unstructured":"Chen L, Liu H, Jiang L, Wang Z, Chang Y, Li N, Feng S (2025) Lipid droplets metabolism mediated by ANXA7-PPAR\u03b3 signaling axis regulates spinal cord injury repair in mice. Adv Sci 12:e2417326. https:\/\/doi.org\/10.1002\/advs.202417326","journal-title":"Adv Sci"},{"key":"5524_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127042","volume":"253","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Gan M, Wang X, Liao T, Chen Q, Lei Y, Chen L, Wang J, Zhao Y, Niu L et al (2023) The global perspective on peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in ectopic fat deposition: a review. Int J Biol Macromol 253:127042. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127042","journal-title":"Int J Biol Macromol"},{"key":"5524_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biom14050596","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang Y, Gu J, Yang Y, Liang J, Wang Y, Ji N, Liu M, Zhang Y, Sun S et al (2024) PPAR\u03b3 antagonists exhibit antitumor effects by regulating ferroptosis and disulfidptosis. Biomolecules. https:\/\/doi.org\/10.3390\/biom14050596","journal-title":"Biomolecules"},{"key":"5524_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117438","volume":"321","author":"X Bai","year":"2024","unstructured":"Bai X, Zheng E, Tong L, Liu Y, Li X, Yang H, Jiang J, Chang Z, Yang H (2024) Angong niuhuang wan inhibit ferroptosis on ischemic and hemorrhagic stroke by activating PPAR\u03b3\/AKT\/GPX4 pathway. J Ethnopharmacol 321:117438. https:\/\/doi.org\/10.1016\/j.jep.2023.117438","journal-title":"J Ethnopharmacol"},{"key":"5524_CR52","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3rd, Kang R, Tang D (2016) Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12:1425\u20131428. https:\/\/doi.org\/10.1080\/15548627.2016.1187366","journal-title":"Autophagy"},{"key":"5524_CR53","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Sci (New York N Y) 290:1717\u20131721. https:\/\/doi.org\/10.1126\/science.290.5497.1717","journal-title":"Sci (New York N Y)"},{"key":"5524_CR54","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/ncb3053","volume":"16","author":"WE Dowdle","year":"2014","unstructured":"Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, Menon S, Wang Z, Honda A, Pardee G et al (2014) Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol 16:1069\u20131079. https:\/\/doi.org\/10.1038\/ncb3053","journal-title":"Nat Cell Biol"},{"key":"5524_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10308","author":"JD Mancias","year":"2015","unstructured":"Mancias JD, Pontano Vaites L, Nissim S, Biancur DE, Kim AJ, Wang X, Liu Y, Goessling W, Kimmelman AC, Harper JW (2015) Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife. https:\/\/doi.org\/10.7554\/eLife.10308","journal-title":"Elife"},{"key":"5524_CR56","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K, Rosenberg PA, Lo DC, Weinberg JM, Linkermann A et al (2014) Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 136:4551\u20134556. https:\/\/doi.org\/10.1021\/ja411006a","journal-title":"J Am Chem Soc"},{"key":"5524_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14101220","author":"J Feng","year":"2025","unstructured":"Feng J, Tao Q, Zhang ZJ, Yu QF, Yang YJ, Li JY (2025) Aspirin eugenol ester alleviates vascular endothelial ferroptosis by enhancing antioxidant ability and inhibiting the JNK\/c-Jun\/NCOA4\/FTH signaling pathway. Antioxidants. https:\/\/doi.org\/10.3390\/antiox14101220","journal-title":"Antioxidants"},{"key":"5524_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01753-y","volume":"9","author":"J Wang","year":"2023","unstructured":"Wang J, Wu N, Peng M, Oyang L, Jiang X, Peng Q, Zhou Y, He Z, Liao Q (2023) Ferritinophagy: research advance and clinical significance in cancers. Cell Death Discov 9:463. https:\/\/doi.org\/10.1038\/s41420-023-01753-y","journal-title":"Cell Death Discov"},{"key":"5524_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.868351","volume":"12","author":"AM Battaglia","year":"2022","unstructured":"Battaglia AM, Sacco A, Perrotta ID, Faniello MC, Scalise M, Torella D, Levi S, Costanzo F, Biamonte F (2022) Iron administration overcomes resistance to erastin-mediated ferroptosis in ovarian cancer cells. Front Oncol 12:868351. https:\/\/doi.org\/10.3389\/fonc.2022.868351","journal-title":"Front Oncol"},{"key":"5524_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154671","volume":"112","author":"ZH Zhu","year":"2023","unstructured":"Zhu ZH, Xu XT, Shen CJ, Yuan JT, Lou SY, Ma XL, Chen X, Yang B, Zhao HJ (2023) A novel sesquiterpene lactone fraction from Eupatorium chinense L. suppresses hepatocellular carcinoma growth by triggering ferritinophagy and mitochondrial damage. Phytomedicine 112:154671. https:\/\/doi.org\/10.1016\/j.phymed.2023.154671","journal-title":"Phytomedicine"},{"key":"5524_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07726-z","volume":"21","author":"Y Mou","year":"2021","unstructured":"Mou Y, Wu J, Zhang Y, Abdihamid O, Duan C, Li B (2021) Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma. BMC Cancer 21:18. https:\/\/doi.org\/10.1186\/s12885-020-07726-z","journal-title":"BMC Cancer"},{"key":"5524_CR62","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202209004","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang H (2022) NCOA4: more than a receptor for ferritinophagy. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202209004","journal-title":"J Cell Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05524-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05524-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:28:30Z","timestamp":1778916510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05524-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5524"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05524-y","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Wenzhou Institute of University of Chinese Academy of Sciences (Wenzhou, China) approved this study. The animal experimental protocols in this study were approved by the Institutional Animal Care and Use Committee, Wenzhou Medical University (approval number wydw2025-0401).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}